Trial Profile
Dexmedetomidine for saphenous nerve blockade in patients undergoing anterior cruciate ligament replacement: a randomized, placebo-controlled, triple blinded study
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Ropivacaine
- Indications Pain
- Focus Therapeutic Use
- 24 Dec 2014 New trial record